A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
Clinical trial NCT06007937 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06007937
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2028-08-17
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.